Life After Cancer: Why the Post-Treatment Period Can Be More Challenging Than the Disease
World Today News,
Why Some Cancer Patients Relapse After Remission: New Insights into Biological and Psychological Triggers Up to 30% of cancer…
Extrapulmonary small cell carcinoma treated with conventional or tumor-targeted topoisomerase I inhibition plus ATR blockade: Clinical outcomes and molecular correlates.
Overview of attention for article published in Journal of Clinical Oncology, May 2026